PT-141 Purity & COA: How PX1 Verifies Every Lot

At a glance: PT-141 purity and testing standards

PX1 Research enforces strict quality control parameters across every batch of synthesized peptides. Every lot of PT-141 undergoes comprehensive analytical testing prior to release, ensuring verified sequence identity and high purity levels.

Our analytical stack evaluates purity via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), confirms structural identity using Electrospray Ionization Mass Spectrometry (ESI-MS), and audits safety through Chromogenic LAL Endotoxin assays.

Researchers can review batch-matched Certificate of Analysis (COA) documents directly online or inside their shipment. When preparing in vitro or preclinical experiments, you can buy lyophilized PT-141 10mg vials with complete analytical transparency.

What is PT-141 (bremelanotide) in preclinical research?

PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide analog derived from alpha-melanocyte-stimulating hormone (α-MSH). Chemically structured as Cyclo(1,6)-Ac-His-D-Phe-Arg-Trp-Lys-OH, bremelanotide functions primarily as a central melanocortin receptor agonist.

In preclinical settings, researchers investigate bremelanotide due to its selective binding profile at central melanocortin receptors—specifically the MC3R and MC4R subtypes within the central nervous system. Unlike peripheral vasoactive agents, melanocortin signaling operates upstream within hypothalamic pathways.

Investigated for melanocortin-receptor signaling linked to sexual-health pathways, pt141 serves as an important tool compound for mapping neurochemical activation, receptor binding kinetics, and downstream cellular cascades. For broader investigation into related signaling molecules, you can explore our complete catalog of research peptides.

Why batch-specific COAs matter for PT-141 research

Peptide synthesis produces secondary target fragments, deletion sequences, and unreacted precursors. Without rigorous analytical post-purification screening, these impurities introduce confounding variables into cell culture assays or animal models.

A generic or recycled COA provides zero guarantee regarding the chemical composition of the vial currently on your lab bench. Synthesis conditions vary between production runs, making lot-by-lot verification mandatory for replicable science.

PX1 Research subjects every individual lot of pt141 to independent, third-party laboratory verification. By matching the batch code printed on your vial to the official testing documentation, researchers ensure that variable peptide concentrations or residual solvents do not compromise experimental baseline data.

The PX1 analytical stack: How we verify PT-141 lot purity

Our multi-tiered analytical stack goes beyond basic identity checks. We utilize a comprehensive testing matrix to validate chemical integrity, physical purity, biological safety, and fill accuracy for every batch of order 10 mg vials of PT-141.

1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Quantifies chemical purity by separating the primary target peptide from synthesis artifacts, truncated fragments, and oxidation products based on hydrophobic interaction.

2. Electrospray Ionization Mass Spectrometry (ESI-MS): Validates exact molecular weight. The resulting mass-to-charge ratio (m/z) confirms correct amino acid sequence assembly and cyclic bond formation.

3. Peptide Content & Amino Acid Analysis (AAA): Determines exact net peptide content relative to counterions (typically acetate) and residual moisture, preventing concentration errors in assay buffer preparation.

4. Bacterial Endotoxin Testing (LAL Assay): Quantifies lipopolysaccharide (LPS) contamination levels to guarantee that pyrogenic agents will not interfere with sensitive cell assays or animal models.

5. Sterility and Fill Mass Audits: Verifies vial sealing integrity, cake structure uniformity, and micro-gravimetric fill weight accuracy across every automated filling run.

6. Retained Sample Protocols: PX1 archives control samples from every lot under climate-controlled conditions (-20°C) for ongoing stability monitoring and longitudinal retrospective testing.

How to read a PT-141 Certificate of Analysis

Interpreting a PT-141 COA requires examining key analytical sections to confirm compound integrity. The top header of every PX1 COA displays the exact Lot Number, Date of Synthesis, Testing Date, and Chemical Formula (C50H68N14O10 with a theoretical molecular weight of 1025.2 g/mol).

Look first at the RP-HPLC chromatogram. A single sharp, prominent peak indicates high purity. The integrated peak area report underneath quantifies total purity percentage by calculating the primary peak area relative to minor baseline peaks. PX1 mandates a baseline purity threshold exceeding 98.0%.

Next, examine the Mass Spectrometry report. The theoretical monoisotopic mass must match the observed m/z peak (typically displaying standard ionized species such as [M+H]+ or [M+2H]2+). Any unexpected major peaks indicate structural degradation or sequence deletion.

Finally, check the safety and physical properties table. This documents physical appearance (a white lyophilized powder), solubility metrics, net peptide weight, and bacterial endotoxin levels expressed in Endotoxin Units per milligram (EU/mg).

Analytical breakdown: RP-HPLC vs. Mass Spectrometry

RP-HPLC and Mass Spectrometry yield distinct yet complementary analytical data. Relying on either technique alone creates critical blind spots in quality assessment.

RP-HPLC separates compounds according to retention time on a non-polar stationary phase. While exceptional at detecting closely related impurities—such as diastereomers, oxidized methionine residues, or truncated peptide sequences—HPLC alone cannot confirm that the main peak possesses the correct molecular weight.

Mass Spectrometry measures the exact mass-to-charge ratio of the eluted molecules. ESI-MS verifies that the synthesized peptide matches the theoretical formula of bremelanotide. Combining RP-HPLC with ESI-MS guarantees both structural correctness and quantitative purity, providing complete confidence when sourcing from the PX1 analytical database.

Endotoxin limits and bioburden control in lyophilizates

Bacterial endotoxins—lipopolysaccharides shed from the outer membrane of Gram-negative bacteria—are potent pyrogenic contaminants. In preclinical studies, elevated endotoxin concentrations trigger non-specific immune activation, altering cytokine expression and skewing receptor signaling responses.

PX1 Research subjects every batch of PT-141 to quantitative Limulus Amebocyte Lysate (LAL) testing compliant with USP <85> guidelines. We enforce strict internal limits, verifying that endotoxin levels remain well below standard industry thresholds (<0.5 EU/mg).

Additionally, our automated glass vial filling and freeze-drying processes adhere to strict bioburden controls (USP <71>), ensuring that lyophilized powders exhibit low background microbial burdens prior to reconstitution.

Supplier verification criteria for melanocortin peptides

Evaluating vendor reliability requires comparing clear operational standards rather than relying on unverified vendor assertions. When choosing a research supply partner, audit vendors against the following criteria:

Purity Verification: Must provide lot-specific RP-HPLC chromatograms showing >=98% purity rather than simple text statements.

Structural Identification: Must perform Mass Spectrometry (ESI-MS or MALDI-TOF) on every production run to verify molecular mass.

Endotoxin Testing: Must offer quantitative LAL assay data verifying minimal bioburden per lot.

Sourcing and Synthesis: Must utilize solid-phase peptide synthesis (SPPS) produced in controlled facilities with direct lot traceability.

Shipping & Fulfillment: Must ship directly from domestic centers (such as PX1's CA and AZ hubs) with same-day dispatch and temperature-monitored handling.

Support and Documentation: Must provide accessible technical support with transparent batch documentation available prior to purchase.

Red flags when sourcing PT-141 online

The research peptide market contains suppliers operating with insufficient quality control. Researchers should recognize several operational red flags before placing orders.

Beware of vendors displaying identical COA images across multiple product batches or hiding batch numbers entirely. A true COA must reference the precise lot number printed on your physical product vial.

Avoid suppliers that fail to publish raw HPLC chromatograms or MS spectral outputs. A text-only PDF listing '99% purity' without supporting graphical baseline data is analytically meaningless.

Be cautious of vendors making therapeutic, clinical, or human administration claims. Authentic laboratory suppliers operate strictly within preclinical research parameters and provide full analytical data for verification. For institutions requiring high volume, review our bulk research peptide orders protocol.

Related melanocortin agonists for comparative research

Researchers studying central melanocortin pathways often evaluate multiple agonist analogs alongside PT-141 to map differential receptor affinity and signaling pathways.

Melanotan II is a non-selective cyclic peptide agonist that binds across MC1R, MC3R, MC4R, and MC5R receptors. Comparing bremelanotide against Melanotan II 10mg vials allows investigators to isolate specific sub-type receptor responses.

For broader neurochemical and central peptide research, labs frequently cross-reference receptor signaling models with neuroprotective peptides such as Semax 30mg vials or explore the complete spectrum of synthetic analogs within the melanocortin research section.

Ordering PT-141 from PX1 Research

When purchasing PT-141 from PX1 Research, your facility receives laboratory-grade lyophilized powder packaged in protective 10 mg sealed glass vials with flip-off caps. Each vial features a lot-specific tracking code linked to its matching COA.

Orders placed before 3:00 PM EST (Monday through Friday) ship same-day from our strategically located fulfillment hubs in California and Arizona. We offer tracked domestic transit options to ensure prompt delivery and minimal transit degradation.

Every batch is backed by full analytical transparency, available lot documentation, and dedicated technical customer support. Secure your research supply today and order 10 mg vials of PT-141 directly from PX1 Research.